marketcaparena
Search

    GYRE

    GYRE THERAPEUTICS, INC.

    Company overview

    Market capitalization
    $835.21M
    Employees
    625
    Latest publication
    2026-09-29
    About GYRE THERAPEUTICS, INC.

    Gyre Therapeutics, Inc., a pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis. The company offers ETUARY (Pirfenidone), an anti-fibrotic drug approved for the treatment of idiopathic pulmonary fibrosis; and under Phase 3 trials for the treatment of pneumoconiosis. It is also involved in the development of F351 (Hydronidone), a structural derivative of ETUARY, under Phase 3 trials for the treatment of chronic hepatitis B (CHB)-associated liver fibrosis; and completed Phase 1 trials for the treatment of liver fibrosis associated with metabolic dysfunction-associated steatohepatitis. In addition, the company develops F573 is in Phase 2 clinical trials for the treatment of acute/acute-on-chronic liver failure. Further, its preclinical products include F230 for the treatment of pulmonary arterial hypertension; and F528 to treat chronic obstructive pulmonary disease. Gyre Therapeutics, Inc. was founded in 2002 and is headquartered in San Diego, California. Gyre Therapeutics, Inc. operates as a subsidiary of GNI USA, Inc.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Revenue1,911,000USD22,519,000USD37,195,000USD30,564,000USD26,771,000USD22,058,000USD27,872,000USD25,488,000USD
    Research Development4,743,000USD6,738,000USD4,815,000USD2,363,000USD3,425,000USD3,095,000USD3,712,000USD2,775,000USD
    Total Operating Expenses11,528,000USD30,647,000USD35,332,000USD22,011,000USD23,449,000USD18,891,000USD26,098,000USD20,297,000USD
    Operating Income335,000USD-9,355,000USD120,000USD6,925,000USD2,171,000USD2,273,000USD597,000USD4,233,000USD
    Income Before Tax-8,790,000USD-9,237,000USD-66,000USD7,629,000USD2,238,000USD4,635,000USD772,000USD3,930,000USD
    Income Tax Expense621,000USD-621,000USD1,300,000USD1,693,000USD662,000USD901,000USD203,000USD1,074,000USD
    Net Income-12,655,000USD-8,616,000USD-1,723,000USD3,610,000USD442,000USD2,698,000USD-99,000USD1,124,000USD
    Cost Of Revenue—1,227,000USD1,743,000USD1,628,000USD1,151,000USD894,000USD1,177,000USD958,000USD
    Gross Profit—21,292,000USD35,452,000USD28,936,000USD25,620,000USD21,164,000USD26,695,000USD24,530,000USD
    Selling General Administrative—7,220,000USD6,701,000USD4,319,000USD4,829,000USD4,955,000USD5,464,000USD3,823,000USD
    Selling And Marketing Expenses—14,136,000USD23,816,000USD15,328,000USD15,194,000USD10,841,000USD16,856,000USD13,699,000USD
    Unclassified Operating Expenses—2,553,000USD——————
    Tax Provision—621,000USD1,300,000USD1,693,000USD662,000USD901,000USD203,000USD1,074,000USD
    Net Income From Continuing Ops—-9,858,000USD-1,366,000USD5,936,000USD1,576,000USD3,734,000USD569,000USD2,856,000USD
    Ebitda—-9,355,000USD815,000USD8,278,000USD2,813,000USD2,808,000USD1,134,000USD4,707,000USD
    Reconciled Depreciation—672,000USD695,000USD649,000USD641,000USD535,000USD471,000USD454,000USD
    Total Other Income Expense Net—118,000USD-186,000USD704,000USD67,000USD2,362,000USD175,000USD-303,000USD
    Minority Interest—1,167,000USD-357,000USD-2,326,000USD-1,134,000USD-1,036,000USD-668,000USD-1,732,000USD
    Ebit——120,000USD7,629,000USD2,172,000USD2,273,000USD663,000USD4,233,000USD
    Depreciation And Amortization——695,000USD649,000USD641,000USD535,000USD471,000USD474,000USD
    Interest Expense———1,073,000USD——350,000USD—
    Interest Income——————346,000USD523,000USD
    Net Interest Income——————346,000USD523,000USD
    SourceDisclosurePreliminaryAmendmentLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · CNYFY 20212021-12-31 · CNYFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Revenue116,588,000USD105,757,000USD113,450,000USD102,290,000CNY7,338,000CNY20,948,000USD—6,000USD
    Cost Of Revenue5,416,000USD3,884,000USD4,636,000USD4,793,000CNY7,670,000CNY9,163,000USD146,000USD21,474,000USD
    Gross Profit111,172,000USD101,873,000USD108,814,000USD97,497,000CNY-332,000CNY11,785,000USD-146,000USD-21,468,000USD
    Research Development13,698,000USD12,024,000USD13,780,000USD16,686,000CNY64,574,000CNY52,975,000USD43,859,000USD21,474,000USD
    Selling General Administrative20,804,000USD16,109,000USD14,662,000USD17,370,000CNY18,820,000CNY16,180,000USD13,418,000USD12,354,000USD
    Selling And Marketing Expenses65,179,000USD57,511,000USD61,159,000USD54,238,000CNY————
    Total Operating Expenses99,681,000USD85,710,000USD176,044,000USD88,294,000CNY83,394,000CNY69,155,000USD57,131,000USD33,828,000USD
    Operating Income11,491,000USD16,163,000USD-67,230,000USD9,203,000CNY-83,726,000CNY-57,370,000USD-57,277,000USD-33,822,000USD
    Interest Income1,747,000USD1,547,000USD1,044,000USD4,883,000CNY382,328CNY———
    Net Interest Income1,747,000USD1,547,000USD1,044,000USD726,000CNY259,958CNY———
    Income Before Tax14,436,000USD23,218,000USD-76,965,000USD9,412,000CNY-87,933,000CNY-56,241,000USD-55,178,000USD-30,055,000USD
    Income Tax Expense4,556,000USD5,320,000USD8,515,000USD5,098,000CNY-39,000CNY-699,000USD-2,291,000USD3,767,000USD
    Tax Provision4,556,000USD5,320,000USD8,515,000USD5,098,000CNY6,168,243CNY———
    Net Income5,027,000USD12,085,000USD-92,933,000USD2,302,000CNY-87,933,000CNY-55,542,000USD-55,178,000USD-30,055,000USD
    Net Income From Continuing Ops9,880,000USD17,898,000USD-85,480,000USD4,314,000CNY23,436,564CNY———
    Ebit11,491,000USD16,229,000USD19,213,000USD9,203,000CNY-87,933,000CNY-56,241,000USD-55,178,000USD-33,971,000USD
    Ebitda14,011,000USD17,817,000USD20,327,000USD10,332,000CNY-87,643,000CNY-56,103,000USD-55,032,000USD-33,822,000USD
    Depreciation And Amortization2,520,000USD1,588,000USD1,114,000USD1,129,000CNY290,000CNY138,000USD146,000USD149,000USD
    Reconciled Depreciation2,520,000USD1,588,000USD1,114,000USD1,129,000CNY1,928,115CNY———
    Total Other Income Expense Net2,945,000USD7,055,000USD-9,735,000USD209,000CNY-4,207,000CNY1,129,000USD2,099,000USD3,767,000USD
    Minority Interest-4,853,000USD-5,813,000USD-7,453,000USD-2,012,000CNY————
    Unclassified Operating Expenses——86,443,000USD—————
    Interest Expense———717,000CNY220,958CNY———
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets53,631,000USD162,015,000USD166,132,000USD159,384,000USD152,646,000USD129,790,000USD125,406,000USD125,240,000USD
    Cash And Equivalents13,322,000USD———————
    Total Current Assets46,993,000USD91,732,000USD102,369,000USD98,576,000USD91,285,000USD68,448,000USD64,786,000USD54,809,000USD
    Total Liabilities7,555,000USD———————
    Total Current Liabilities5,497,000USD19,788,000USD18,286,000USD15,913,000USD16,920,000USD18,991,000USD19,516,000USD14,716,000USD
    Short Long Term Debt23,146USD———————
    Net Receivables2,442,000USD22,763,000USD36,946,000USD25,877,000USD25,358,000USD22,518,000USD29,153,000USD20,774,000USD
    Inventory11,352,000USD11,352,000USD10,171,000USD8,854,000USD8,861,000USD7,878,000USD6,337,000USD6,379,000USD
    Property Plant Equipment Net-55,000USD23,572,000USD24,730,000USD23,608,000USD23,401,000USD23,518,000USD25,698,000USD26,426,000USD
    Intangible Assets—4,627,000USD4,727,000USD4,847,000USD4,962,000USD5,083,000USD1,705,000USD1,663,000USD
    Other Current Assets—20,116,000USD2,827,000USD23,443,000USD2,701,000USD8,161,000USD2,625,000USD2,564,000USD
    Total Liab—25,030,000USD23,850,000USD21,969,000USD23,203,000USD25,488,000USD27,004,000USD26,766,000USD
    Total Stockholder Equity—101,309,000USD106,031,000USD101,920,000USD92,026,000USD68,123,000USD63,319,000USD63,179,000USD
    Other Current Liab—15,641,000USD14,572,000USD12,085,000USD15,048,000USD13,068,000USD15,708,000USD10,801,000USD
    Common Stock—91,000USD91USD91,000USD91,000USD87,000USD86,000USD85,000USD
    Capital Stock—91,000USD91,000USD91,000USD91,000USD87,000USD86,000USD85,000USD
    Retained Earnings—-77,667,000USD-68,426,000USD-66,703,000USD-70,313,000USD-70,755,000USD-73,453,000USD-73,354,000USD
    Cash—37,501,000USD37,070,000USD40,402,000USD36,491,000USD15,045,000USD11,813,000USD15,866,000USD
    Cash And Short Term Investments—37,501,000USD52,425,000USD40,402,000USD54,365,000USD29,891,000USD26,671,000USD25,092,000USD
    Net Debt—-36,678,000USD-36,131,000USD-39,237,000USD-35,098,000USD-13,460,000USD-10,215,000USD-14,071,000USD
    Short Term Debt—751,000USD636,000USD626,000USD622,000USD805,000USD713,000USD694,000USD
    Short Long Term Debt Total—823,000USD939,000USD1,165,000USD1,393,000USD1,585,000USD1,598,000USD1,795,000USD
    Long Term Investments—29,419,000USD23,516,000USD20,317,000USD21,528,000USD21,367,000USD24,568,000USD29,515,000USD
    Short Term Investments—12,307,000USD15,355,000USD19,647,000USD17,874,000USD14,846,000USD14,858,000USD9,226,000USD
    Accounts Payable—265,000USD124,000USD556,000USD71,000USD122,000USD108,000USD303,000USD
    Property Plant Equipment Gross—31,738,000USD32,306,000USD30,542,000USD29,826,000USD29,595,000USD31,297,000USD31,749,000USD
    Accumulated Other Comprehensive Income—586,000USD2,319,000USD-1,700,000USD811,000USD612,000USD501,000USD2,152,000USD
    Common Stock Shares Outstanding—91,344,584shares102,940,872shares102,701,707shares102,701,707shares101,970,672shares102,293,526shares102,640,373shares
    Non Current Assets Total—70,283,000USD63,763,000USD60,808,000USD61,361,000USD61,342,000USD60,620,000USD70,431,000USD
    Non Current Liabilities Total—5,242,000USD5,564,000USD6,056,000USD6,283,000USD6,497,000USD7,488,000USD12,050,000USD
    Non Current Liabilities Other—1,458,000USD1,448,000USD1,427,000USD1,427,000USD1,399,000USD7,000USD2,000USD
    Non Currrent Assets Other—34,361,000USD27,433,000USD25,639,000USD5,336,000USD5,556,000USD3,030,000USD7,666,000USD
    Net Working Capital—71,944,000USD84,083,000USD82,663,000USD74,365,000USD49,457,000USD45,270,000USD40,093,000USD
    Unclassified Current Assets—-12,307,000USD—-19,647,000USD————
    Unclassified Non Current Assets—-21,696,000USD-16,643,000USD-13,603,000USD6,134,000USD5,818,000USD-64,328,020USD5,161,000USD
    Unclassified Current Liabilities—3,131,000USD2,940,000USD2,646,000USD1,084,000USD4,873,000USD2,831,000USD2,842,000USD
    Unclassified Non Current Liabilities—3,784,000USD4,116,000USD4,629,000USD4,856,000USD5,098,000USD7,481,000USD12,048,000USD
    Unclassified Equity—178,208,000USD172,046,909USD170,141,000USD161,346,000USD138,092,000USD136,099,000USD134,211,000USD
    Current Deferred Revenue——14,000USD—95,000USD123,000USD156,000USD76,000USD
    Other Assets——————69,947,020USD—
    SourceDisclosurePreliminaryAmendmentLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · CNYFY 20212021-12-31 · CNYFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets166,132,000USD125,406,000USD116,539,000USD84,753,000CNY55,662,000CNY94,846,000USD98,554,000USD124,920,000USD
    Intangible Assets4,727,000USD1,705,000USD1,698,000USD1,856,000CNY20,764,343CNY———
    Other Current Assets2,827,000USD2,625,000USD2,592,000USD2,742,000CNY2,807,000CNY6,843,000USD4,201,000USD3,864,000USD
    Total Liab23,850,000USD27,004,000USD102,590,000USD12,536,000CNY14,573,000CNY18,777,000USD30,218,000USD4,975,000USD
    Total Stockholder Equity106,031,000USD63,319,000USD-15,828,000USD42,522,000CNY41,089,000CNY76,069,000USD68,336,000USD119,945,000USD
    Other Current Liab14,572,000USD15,708,000USD14,349,000USD11,628,000CNY5,539,000CNY9,219,000USD9,137,000USD3,553,000USD
    Common Stock91USD86,000USD77,000USD64,000CNY31,000CNY22,000USD12,000USD12,000USD
    Capital Stock91,000USD86,000USD77,000USD64,000CNY9,619,868CNY———
    Retained Earnings-68,426,000USD-73,453,000USD-85,538,000USD10,055,000CNY-402,694,000CNY-314,761,000USD-258,519,999USD-203,342,000USD
    Cash37,070,000USD11,813,000USD33,509,000USD25,175,000CNY44,347,000CNY30,360,000USD15,369,000USD31,213,000USD
    Cash And Short Term Investments52,425,000USD26,671,000USD33,509,000USD25,175,000CNY46,851,000CNY79,354,000USD76,865,000USD120,127,000USD
    Total Current Assets102,369,000USD64,786,000USD57,221,000USD49,653,000CNY51,476,000CNY89,510,000USD96,066,000USD123,991,000USD
    Total Current Liabilities18,286,000USD19,516,000USD20,047,000USD12,242,000CNY14,165,000CNY17,796,000USD28,899,000USD4,801,000USD
    Current Deferred Revenue14,000USD156,000USD79,000USD167,000CNY230,000CNY1,983,000USD15,000,000USD—
    Net Debt-36,131,000USD-10,215,000USD-33,100,000USD-24,562,000CNY-41,962,000CNY-28,716,000USD-13,567,000USD-31,213,000USD
    Short Term Debt636,000USD713,000USD210,000USD492,000CNY1,977,000CNY663,000USD483,000USD—
    Short Long Term Debt Total939,000USD1,598,000USD409,000USD613,000CNY2,385,000CNY1,644,000USD1,802,000USD—
    Long Term Investments23,516,000USD24,568,000USD23,431,000USD7,394,000CNY0CNY———
    Short Term Investments15,355,000USD14,858,000USD0USD10,597,000CNY2,504,000CNY48,994,000USD61,496,000USD88,914,000USD
    Net Receivables36,946,000USD29,153,000USD16,839,000USD15,614,000CNY1,818,000CNY3,313,000USD15,000,000USD—
    Inventory10,171,000USD6,337,000USD4,281,000USD6,122,000CNY5,719,552CNY1,000USD——
    Accounts Payable124,000USD108,000USD355,000USD122,000CNY6,419,000CNY5,931,000USD4,279,000USD1,248,000USD
    Property Plant Equipment Net24,730,000USD25,698,000USD23,777,000USD18,375,000CNY3,714,000CNY2,265,000USD2,231,000USD386,000USD
    Property Plant Equipment Gross32,306,000USD31,297,000USD29,535,000USD23,932,000CNY20,829,607CNY———
    Accumulated Other Comprehensive Income2,319,000USD501,000USD1,454,000USD-392,000CNY40,225,443CNY5,000USD34,000USD-4,000USD
    Common Stock Shares Outstanding103,180,037shares102,293,526shares65,831,675shares75,686,406shares30,640,977shares19,179,299shares12,004,489shares11,213,884shares
    Non Current Assets Total63,763,000USD60,620,000USD59,318,000USD35,100,000CNY4,186,000CNY5,335,999USD2,487,999USD929,000USD
    Non Current Liabilities Total5,564,000USD7,488,000USD82,543,000USD294,000CNY408,000CNY981,000USD1,318,999USD174,000USD
    Non Current Liabilities Other1,448,000USD7,000USD49,000USD55,000CNY————
    Non Currrent Assets Other27,433,000USD3,030,000USD5,717,000USD7,475,000CNY472,000CNY527,999USD256,999USD543,000USD
    Net Working Capital84,083,000USD45,270,000USD37,174,000USD37,411,000CNY34,555,624CNY———
    Unclassified Non Current Assets-16,643,000USD5,619,000USD3,202,000USD—-20,764,343CNY2,543,000USD——
    Unclassified Current Liabilities2,940,000USD2,831,000USD5,054,000USD—————
    Unclassified Non Current Liabilities4,116,000USD7,481,000USD82,494,000USD———1,318,999USD—
    Unclassified Equity172,046,909USD136,099,000USD68,102,000USD32,731,000CNY393,906,689CNY390,803,000USD326,809,999USD323,279,000USD
    Good Will——1,493,000USD—————
    Unclassified Current Assets———-10,597,000CNY-5,719,552CNY———
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Net Income-12,655,000USD-8,691,000USD-2,402,000USD5,936,000USD1,576,000USD3,734,000USD569,000USD1,124,000USD
    Depreciation181,000USD672,000USD656,000USD649,000USD641,000USD535,000USD471,000USD454,000USD
    Stock Based Compensation245,000USD2,583,000USD4,597,000USD1,147,000USD906,000USD507,000USD567,000USD237,000USD
    Investing Cash Flow5,904,000USD———————
    Financing Cash Flow-1,001,000USD———————
    End Cash Flow13,322,000USD———————
    Other Non Cash Items—2,423,000USD159,000USD-72,000USD-446,000USD-1,368,000USD-152,000USD2,023,000USD
    Change To Account Receivables—10,475,000USD-9,673,000USD-1,193,000USD-2,608,000USD1,521,000USD-5,472,000USD-536,000USD
    Change To Inventory—-1,014,999USD-1,208,000USD72,000USD-954,000USD-1,541,000USD-118,000USD-636,000USD
    Change In Working Capital—9,514,000USD-9,466,000USD-2,453,000USD-289,000USD-3,346,000USD-3,621,000USD-1,925,000USD
    Total Cash From Operating Activities—3,180,000USD-5,625,000USD4,676,000USD2,088,000USD-129,000USD-2,758,000USD1,676,000USD
    Capital Expenditures—-178,000USD-144,000USD-683,000USD-279,000USD-821,000USD-745,000USD-693,000USD
    Free Cash Flow—3,002,000USD-5,769,000USD3,993,000USD1,809,000USD-950,000USD-3,503,000USD983,000USD
    Investments—-2,878,000USD1,977,000USD-1,247,000USD-3,042,000USD1,967,000USD-2,004,000USD-2,387,000USD
    Total Cashflows From Investing Activities—-3,055,000USD1,848,000USD-1,247,000USD-3,042,000USD1,967,000USD-2,004,000USD-2,387,000USD
    Total Cash From Financing Activities—21,000USD318,000USD365,000USD22,351,000USD1,344,000USD964,000USD374,000USD
    Issuance Of Capital Stock—0USD0USD0USD23,000,000USD509,000USD—0USD
    Change In Cash—431,000USD-3,332,000USD3,911,000USD21,446,000USD3,232,000USD-4,053,000USD-231,000USD
    Begin Period Cash Flow—37,070,000USD40,402,000USD36,491,000USD15,045,000USD11,813,000USD15,866,000USD16,097,000USD
    End Period Cash Flow—37,501,000USD37,070,000USD40,402,000USD36,491,000USD15,045,000USD11,813,000USD15,866,000USD
    Other Cashflows From Investing Activities—-2,877,000USD-30,000USD-15,000USD-5,000USD-698,000USD-672,000USD-15,718,000USD
    Other Cashflows From Financing Activities—21,000USD318,000USD365,000USD-649,000USD835,000USD964,000USD-50,000USD
    Unclassified Operating Cash Flow—-3,321,000USD——————
    Unclassified Investing Cash Flow—2,878,000USD———1,519,000USD1,417,000USD16,411,000USD
    SourceDisclosurePreliminaryAmendmentLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · CNYFY 20212021-12-31 · CNYFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income9,880,000USD17,898,000USD-85,480,000USD4,314,000CNY-87,933,000CNY-56,241,000USD-55,178,000USD-30,055,000USD
    Depreciation2,481,000USD1,588,000USD1,114,000USD1,129,000CNY290,000CNY138,000USD146,000USD149,000USD
    Stock Based Compensation7,157,000USD831,000USD7,281,000USD13,366,000CNY3,405,000CNY3,627,000USD3,204,000USD2,606,000USD
    Other Non Cash Items-1,845,000USD-7,268,000USD96,679,000USD503,000CNY3,888,000CNY3,627,000USD11,419,000USD116,000USD
    Change To Account Receivables-11,953,000USD-9,285,000USD1,302,000USD-7,920,000CNY1,495,000CNY11,687,000USD-15,000,000USD—
    Change To Inventory-3,631,000USD-2,139,000USD1,747,000USD-879,000CNY3,880,000CNY-3,043,000USD-490,000USD—
    Change In Working Capital-15,554,000USD-15,688,000USD7,458,000USD-7,797,000CNY483,000CNY-2,572,000USD8,215,000USD-1,369,000USD
    Total Cash From Operating Activities1,010,000USD-3,641,000USD25,892,000USD10,677,000CNY-83,755,000CNY-55,048,000USD-43,613,000USD-28,553,000USD
    Capital Expenditures-1,190,000USD-3,128,000USD-8,586,000USD-4,998,000CNY-839,000CNY-267,000USD-64,000USD-376,000USD
    Free Cash Flow-180,000USD-6,769,000USD17,306,000USD5,679,000CNY-84,594,000CNY-55,315,000USD-43,677,000USD-28,929,000USD
    Investments1,419,000USD-19,884,000USD-19,760,000USD-13,814,000CNY-8,190,803CNY———
    Total Cashflows From Investing Activities-474,000USD-19,884,000USD-19,760,000USD-13,814,000CNY48,189,000CNY9,663,000USD27,392,000USD-71,321,000USD
    Total Cash From Financing Activities24,378,000USD2,102,000USD2,500,000USD-45,011,000CNY49,553,000CNY60,376,000USD327,000USD111,332,000USD
    Issuance Of Capital Stock23,509,000USD773,000USD2,500,000USD0CNY————
    Change In Cash25,257,000USD-21,696,000USD8,334,000USD-5,028,000CNY13,987,000CNY14,991,000USD-15,894,000USD11,458,000USD
    Begin Period Cash Flow11,813,000USD33,509,000USD25,175,000USD30,203,000CNY30,360,000CNY15,369,000USD31,263,000USD19,805,000USD
    End Period Cash Flow37,070,000USD11,813,000USD33,509,000USD25,175,000CNY44,347,000CNY30,360,000USD15,369,000USD31,263,000USD
    Other Cashflows From Investing Activities686,000USD-412,000USD471,000USD-13,000CNY49,028,000CNY9,930,000USD27,456,000USD-70,945,000USD
    Other Cashflows From Financing Activities-1,487,000USD1,329,000USD2,500,000USD486,279CNY6,702,907CNY9,663,000USD327,000USD9,652,000USD
    Unclassified Operating Cash Flow-1,109,000USD-1,002,000USD-1,160,000USD—-3,888,000CNY-3,627,000USD-11,419,000USD—
    Unclassified Investing Cash Flow-1,389,000USD3,540,000USD8,115,000USD5,011,000CNY8,190,803CNY———
    Unclassified Financing Cash Flow2,356,000USD—-2,500,000USD—49,553,000CNY50,713,000USD—101,680,000USD
    Net Borrowings———-466,279CNY-6,702,907CNY———
    Dividends Paid———-45,031,000CNY0CNY———
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q1 2026Quarterly · 2026-03-31ProductContiva849USD0001193125-26-214676
    Q1 2026Quarterly · 2026-03-31ProductEtorel672USD0001193125-26-214676
    Q1 2026Quarterly · 2026-03-31ProductOther Product31USD0001193125-26-214676
    Q1 2026Quarterly · 2026-03-31ProductProduct22,500,000USD0001193125-26-214676
    Q1 2026Quarterly · 2026-03-31SegmentAll Other Segments0USD0001193125-26-214676
    Q1 2026Quarterly · 2026-03-31SegmentGyre0USD0001193125-26-214676
    Q1 2026Quarterly · 2026-03-31SegmentGyre Pharmaceuticals22,519,000USD0001193125-26-214676
    FY 2025Yearly · 2025-12-31ProductContiva5,520,000USD0001193125-26-106251
    FY 2025Yearly · 2025-12-31ProductEtorel4,619,000USD0001193125-26-106251
    FY 2025Yearly · 2025-12-31ProductOther Product312,000USD0001193125-26-106251
    FY 2025Yearly · 2025-12-31ProductProduct106,137,000USD0001193125-26-106251
    Q1 2025Quarterly · 2025-03-31ProductContiva279USD0001193125-26-214676
    Q1 2025Quarterly · 2025-03-31ProductOther Product73USD0001193125-26-214676
    Q1 2025Quarterly · 2025-03-31ProductProduct22,100,000USD0001193125-26-214676
    Q1 2025Quarterly · 2025-03-31SegmentAll Other Segments0USD0001193125-26-214676
    Q1 2025Quarterly · 2025-03-31SegmentGyre0USD0001193125-26-214676
    Q1 2025Quarterly · 2025-03-31SegmentGyre Pharmaceuticals22,058,000USD0001193125-26-214676
    FY 2024Yearly · 2024-12-31ProductOther Product748,000USD0001193125-26-106251
    FY 2024Yearly · 2024-12-31ProductProduct105,009,000USD0001193125-26-106251
    Q3 2024Quarterly · 2024-09-30ProductOther Product203,000USD0001193125-25-272383
    Q3 2024Quarterly · 2024-09-30ProductProduct25,500,000USD0001193125-25-272383
    FY 2022Yearly · 2022-12-31ProductLicense1,414,000CNY0000950170-24-037242
    FY 2022Yearly · 2022-12-31ProductProduct100,876,000CNY0000950170-24-037242
    FY 2020Yearly · 2020-12-31ProductCollaboration Revenue5,848,000USD0001564590-22-012877
    FY 2020Yearly · 2020-12-31ProductExclusive License100,000USD0001564590-22-012877
    FY 2020Yearly · 2020-12-31ProductLicense Revenue15,100,000USD0001564590-22-012877
    Q3 2020Quarterly · 2020-09-30ProductCollaboration Revenue861,000USD0001564590-21-056450
    Q3 2020Quarterly · 2020-09-30ProductLicense Revenue32,000USD0001564590-21-056450
    Q2 2020Quarterly · 2020-06-30ProductCollaboration Revenue1,635,000USD0001564590-21-041373
    Q2 2020Quarterly · 2020-06-30ProductLicense Revenue23,000USD0001564590-21-041373
    Q1 2020Quarterly · 2020-03-31ProductCollaboration Revenue1,300,000USD0001564590-21-024728
    Q1 2020Quarterly · 2020-03-31ProductExclusive License100,000USD0001564590-21-024728
    Q1 2020Quarterly · 2020-03-31ProductLicense Revenue15,000,000USD0001564590-21-024728

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.